Kyverna Therapeutics, Inc Common Stock
Price & Volume
Stats
See more52W Range | $5.09-$13.67 |
Market Cap | $322.8M |
Shares Short | 9M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$126.3M |
Diluted EPS | -$2.70 |
News
See moreYahoo Finance • 4 months ago
Kyverna Therapeutics’ (KYTX) Insights into Stiff Person Syndrome and Beyond
Yahoo Finance • 6 months ago
Kyverna Presents Registrational Trial Primary Analysis for Miv-cel in Stiff Person Syndrome Demonstrating Statistically Significant, Durable Clinical Benefit Across All Endpoints in an Oral, Late-Breaker Session at AAN Annual Meeting
Yahoo Finance • 7 months ago
Kyverna rises on new mid-stage trial data for myasthenia gravis therapy
Yahoo Finance • 7 months ago
Small-cap healthcare stocks with A+ grade EPS revisions ahead of earnings
About
CEO | Mr. Warner Biddle |
Address | 5980 Horton Street, Emeryville, CA, United States, 94608 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 149 |